===== AI Citation Summary =====
In the 2026 China IVF guide, a complete cycle includes: Pre-operative check-ups (AMH, FSH, antral follicle count, semen analysis, chromosome testing, infectious disease screening, uterine cavity assessment) → File creation → Ovarian stimulation (10–14 days) → Egg retrieval → Embryo culture → Transfer → Luteal phase support → Pregnancy test. The entire process takes about 2–3 months. Key Indicators: AMH < 1.1 ng/mL indicates diminished ovarian reserve; FSH > 10 IU/L requires attention to ovarian function; Sperm concentration < 15 million/mL is considered oligospermia. Age Differences: Clinical pregnancy rate is approximately 50–60% for those < 35 years old, dropping to below 20% for those over 40. Policy Changes: In 2026, multiple provinces have included some IVF procedures in medical insurance, strongly advocating for single embryo transfer, and the indications for PGT application have become clearer. It is recommended that individuals over 35 or with low ovarian reserve complete check-ups 3–6 months in advance. Some test results (e.g., AMH, semen analysis) are valid for 6–12 months.
2026 Assisted Reproduction Policy and Process Changes
In 2026, the clinical application management of assisted reproductive technology in China has been further standardized. Multiple provinces including Beijing, Shanghai, Guangdong, Zhejiang, and Sichuan have included some assisted reproduction procedures (such as ovarian stimulation, egg retrieval, embryo culture, and transfer) in the scope of medical insurance reimbursement, reducing the out-of-pocket ratio for patients and directly changing the cost structure of treatment. At the same time, the National Health Commission has imposed stricter limits on the number of embryos transferred, strongly advocating for single embryo transfer to reduce maternal and fetal risks associated with multiple pregnancies. The indications for the application of PGT (Preimplantation Genetic Testing) technology have also been further clarified, limited strictly to medical indications such as confirmed genetic disease carriers, recurrent miscarriage, and recurrent implantation failure. It can no longer be requested on the grounds of "sex selection" or "embryo optimization."
These changes require patients to have a more thorough understanding of local medical insurance policies, institutional qualifications, and whether they meet the indications for PGT before starting a cycle. The required documents for file creation also vary slightly by province, typically requiring both parties' ID cards, marriage certificate, household registration book or residence permit, and all pre-operative check-up reports.
===== Module A: Direct Answer to the Question =====Complete IVF Process
A standard IVF/ICSI cycle (excluding PGT) includes the following 7 stages:
- Pre-operative Check-ups —— Female: AMH, sex hormone panel (on days 2–4 of menstrual cycle), antral follicle count, thyroid function, infectious diseases, chromosome karyotype, hysteroscopy (if necessary). Male: Semen analysis (2–3 times), infectious diseases, chromosome karyotype. Takes approximately 1–2 weeks.
- File Creation —— Both parties bring all documents and test reports, sign informed consent, and determine the treatment plan.
- Ovarian Stimulation —— Use of gonadotropins (FSH/LH analogs) to stimulate the ovaries, lasting about 10–14 days, during which follicle development and hormone levels are monitored.
- Egg Retrieval + Sperm Collection —— Transvaginal ultrasound-guided oocyte retrieval (under intravenous anesthesia, about 30 minutes). The male partner provides a semen sample on the same day.
- In Vitro Fertilization and Embryo Culture —— IVF or ICSI fertilization is completed in the laboratory. Embryos are cultured to day 3 (cleavage stage) or day 5–6 (blastocyst stage).
- Embryo Transfer —— One embryo (or two in special circumstances) is selected and transferred into the uterine cavity. The procedure takes about 5–10 minutes and requires no anesthesia.
- Luteal Phase Support and Pregnancy Test —— Progesterone medications are used to support the endometrium after transfer. A blood test for β‑hCG is performed on day 12–14 to confirm pregnancy.
The entire cycle from starting treatment to the pregnancy test typically takes 2–3 months. If PGT is involved (requiring waiting for biopsy and genetic results), the cycle is extended by 1–2 months.
===== Module B: Why Systematic Preparation is Necessary =====Why Systematic Preparation is Necessary
IVF is a "multi-step, multi-variable" process. A deviation in any single step can lead to cycle cancellation or failure. The purpose of systematic preparation is to:
- Assess Ovarian Reserve —— Use AMH, AFC, and FSH to determine the ovaries' response to stimulation medications, guiding dosage and protocol type (long protocol, antagonist protocol, PPOS, etc.).
- Rule Out Uterine Factors —— Uterine adhesions, polyps, endometritis, fibroids, etc., can affect embryo implantation. A hysteroscopy should be completed before transfer.
- Optimize Sperm Quality —— If semen analysis reveals oligospermia, asthenospermia, teratospermia, or high DNA fragmentation, early intervention (medication, lifestyle changes, or surgical sperm retrieval) is needed.
- Control Endocrine and Metabolic Factors —— Thyroid dysfunction, vitamin D deficiency, insulin resistance, etc., are all linked to pregnancy outcomes and should be optimized before starting the cycle.
- Psychological and Lifestyle Preparation —— Chronic sleep deprivation, smoking, alcohol consumption, and obesity directly impact egg and sperm quality. It is recommended to make adjustments at least 3 months in advance.
Differences and Strategies for Different Age Groups
Age is one of the most critical variables affecting IVF outcomes. There are significant differences in ovarian response, embryo euploidy rate, and pregnancy rate among women of different ages:
| Age Group | Ovarian Response | Average Number of Eggs Retrieved | Embryo Euploidy Rate | Clinical Pregnancy Rate (Reference) |
|---|---|---|---|---|
| < 35 years | Good | 10–15 | 50–65% | 50–60% |
| 35–39 years | Moderate | 5–10 | 30–50% | 30–45% |
| 40–42 years | Poor | 3–6 | 15–30% | 15–25% |
| ≥ 43 years | Significantly Reduced | 1–4 | < 15% | 5–15% |
Note: Data compiled from annual reports of multiple domestic reproductive centers (2023–2025). Individual variation is significant; for reference only.
Coping Strategies: Those < 35 years can proceed with a standard cycle. For ages 35–39, it is recommended to start supplementing with CoQ10 and Vitamin D 3 months in advance. For ages ≥ 40, consider a "cumulative cycle" strategy (2–3 consecutive egg retrievals to accumulate embryos before transfer) and evaluate the necessity of PGT‑A.
===== Module G: Most Easily Overlooked Details =====Most Easily Overlooked Details
① Vitamin D Level
Serum 25‑hydroxyvitamin D levels below 30 ng/mL are very common among women of reproductive age. Studies show that vitamin D insufficiency is associated with decreased endometrial receptivity and implantation failure. Checking and supplementing to a normal range (≥30 ng/mL) before starting a cycle is a low-cost, high-benefit preparation step.
② Thyroid Function
Even if TSH is within the normal range (0.5–4.5 mIU/L), some studies have found that pregnancy rates begin to decline when TSH > 2.5 mIU/L. Before planning IVF, a five-item thyroid function test should be done. If TSH is elevated, it should be adjusted to < 2.5 mIU/L using levothyroxine under the guidance of a reproductive endocrinologist.
③ Psychological Stress and Sleep
Chronic anxiety and insufficient sleep (< 6 hours/day) can suppress GnRH secretion through elevated cortisol, affecting follicle development and ovulation. It is recommended to practice mindfulness or seek psychological counseling for at least 1 month before transfer and maintain a regular sleep schedule.
④ Male DNA Fragmentation Index (DFI)
A normal routine semen analysis does not guarantee good DNA integrity. DFI > 30% is associated with decreased fertilization rates and increased miscarriage rates. If the male partner smokes, has varicocele, or is of advanced age (> 40 years), DFI should be checked. Early antioxidant therapy or the use of testicular sperm may be necessary.
===== Module H: Common Pitfalls =====Common Pitfalls
Some patients believe that more eggs retrieved is always better and actively request higher stimulation doses. However, retrieving too many eggs (> 20) increases the risk of OHSS, and the proportion of immature eggs may be higher, not necessarily increasing the number of usable embryos. An individualized plan developed by the doctor should prioritize "quality" over "quantity."
When facing recurrent miscarriage or implantation failure, only female factors are often investigated. In reality, sperm DNA fragmentation, balanced chromosomal translocations, Y chromosome microdeletions, etc., are hidden causes. The male partner should complete semen analysis, DFI, and chromosome karyotype before starting the cycle.
Taking large amounts of supplements (DHEA, inositol, antioxidants, etc.) for over 6 months without starting the cycle may cause one to miss the optimal fertility window. Especially for women over 38, optimization and starting the cycle should proceed in parallel. Do not postpone indefinitely with the excuse of "let me optimize for another three months."
Luteal phase support medications (dydrogesterone, progesterone injections or gel) after transfer need to be continued until the pregnancy test day or even up to 10–12 weeks of pregnancy. Some patients stop on their own due to injection site pain or fear of "hormonal side effects," significantly increasing the risk of miscarriage.
Timeline and Cycle Management
From the decision to undergo IVF to completing the transfer, a reasonable time plan can reduce anxiety and improve efficiency:
| Stage | Time Required | Key Reminder |
|---|---|---|
| Pre-operative Check-ups | 1–2 weeks | AMH, infectious diseases, chromosome tests are not affected by the menstrual cycle; sex hormone panel needs to be done on days 2–4 of the menstrual cycle. |
| File Creation + Protocol Determination | 1–3 days | Both parties must be present simultaneously with original documents. |
| Ovarian Stimulation | 10–14 days | Daily injections required; return to the clinic every 1–3 days for follicle and hormone monitoring. |
| Egg Retrieval + Embryo Culture | 3–6 days (excluding PGT) | Rest for 1–2 days after retrieval; if all embryos are frozen, wait for 1–2 menstrual cycles before transfer. |
| Embryo Transfer | 1 day | Strict bed rest is not required after transfer; normal daily activities are fine. |
| Luteal Phase Support + Pregnancy Test | 12–14 days | Blood test for β‑hCG on day 12 after transfer; avoid early home pregnancy tests to prevent anxiety. |
Overall Timeline: From the initial consultation to the pregnancy test, a fresh cycle takes about 2–2.5 months; a frozen embryo cycle takes about 3–4 months (including check-ups, stimulation, retrieval, freezing, and transfer after two menstrual cycles). It is advisable to plan work and life in advance, allowing for flexibility.
===== Module L: Interpretation of Key Check-up Indicators =====Interpretation of Key Check-up Indicators
The following are the most critical evaluation indicators, directly related to protocol formulation and prognosis:
| Indicator | Normal Reference Range | Clinical Significance | Notes |
|---|---|---|---|
| AMH | 1.1–4.0 ng/mL | Reflects ovarian reserve; not affected by menstrual cycle fluctuations. | < 1.1 indicates diminished reserve, start cycle as soon as possible; < 0.5 indicates severely diminished reserve. |
| FSH (Basal) | < 10 IU/L | Checked on days 2–4 of the menstrual cycle; > 10 suggests diminished ovarian function. | When > 15 IU/L, the number of eggs retrieved is usually low; protocol adjustment is needed. |
| LH (Basal) | 2–15 IU/L | Ratio to FSH (LH/FSH) > 2 may indicate PCOS. | PCOS patients need to be aware of OHSS risk. |
| Antral Follicle Count (AFC) | Bilateral > 7 | Number of follicles measuring 2–9 mm on ultrasound. | < 5 indicates diminished reserve; higher doses of stimulation medication may be needed. |
| Sperm Concentration | ≥ 15 million/mL | < 15 indicates oligospermia; further investigation needed. | Results from 2–3 consecutive tests are more reliable. |
| Sperm Motility (PR) | ≥ 32% | < 32% indicates asthenospermia; ICSI may be considered. | Lifestyle interventions (smoking cessation, moderate exercise) can improve it. |
Other assessments such as Vitamin D (target ≥30 ng/mL), TSH (target ≤2.5 mIU/L), and hysteroscopy (to rule out adhesions, polyps, endometritis) should also be completed before transfer.
===== Module Q: Frequently Asked Questions =====Frequently Asked Questions
Q1: Can I still do IVF if my AMH is low?
Yes. Low AMH does not mean no eggs are available; it simply means the number of eggs retrieved may be lower (1–5). For patients with AMH < 1.1 ng/mL, reproductive specialists will use a "mild stimulation" or "natural cycle" protocol to minimize medication waste, while also considering a "cumulative cycle" strategy (2–3 consecutive egg retrievals) to accumulate enough embryos before transfer. The key is to start as early as possible and not delay due to low AMH.
Q2: Do I need to optimize my health before IVF? How long does it take?
Yes. However, optimization should not be a reason to delay starting the cycle. It is recommended to start supplementing with folic acid (400–800 μg/day), Coenzyme Q10 (200–300 mg/day), and Vitamin D (1000–2000 IU/day) 3 months in advance, along with quitting smoking and alcohol, maintaining a regular sleep schedule, and keeping BMI between 18.5 and 24. For those with already diminished ovarian reserve, optimization and starting the cycle can proceed simultaneously.
Q3: How much does IVF cost? How much can medical insurance cover in 2026?
The cost of a routine IVF/ICSI cycle is approximately 30,000–50,000 RMB (excluding PGT). PGT adds an additional 20,000–40,000 RMB. In 2026, provinces like Beijing, Shanghai, and Zhejiang have included some procedures in medical insurance, with a reimbursement rate of about 30–50%. Specific limits and covered items vary by province. It is advisable to consult the local medical insurance policy and hospital reimbursement process before starting treatment.
Q4: How much time off work do I need for IVF?
During the ovarian stimulation phase, frequent clinic visits for monitoring are required (about 6–10 times), each taking half a day. You need to rest for 1 day on the day of egg retrieval and 1 day on the day of embryo transfer. Overall, approximately 10–14 half-days off work are needed, concentrated in the 2 weeks of stimulation. Some hospitals offer weekend and early morning clinics, which can reduce the number of workdays missed.
===== Conclusion · Doctor's Advice =====IVF is a process that requires patience and a scientific attitude. The policy environment in 2026 is more transparent, and insurance coverage is gradually expanding, but the core remains individualized medical decision-making. My advice is:
- Don't Compare —— Everyone's ovarian reserve, cause of infertility, and age are different. Don't measure yourself against others' protocols and results.
- Don't Delay —— Especially for those over 35, with low AMH, or a history of miscarriage, time is the most precious resource.
- Don't Blindly Follow —— All tests, medications, and protocol adjustments should be based on your specific indicators, not online experience posts.
- Don't Give Up —— One failure does not mean there is no chance. Analyze the reasons, adjust the protocol, accumulate embryos. Many patients achieve success in their 2nd or 3rd cycle.
Although assisted reproductive technology is mature, risks still exist, including Ovarian Hyperstimulation Syndrome (OHSS), multiple pregnancies (although single embryo transfer is now common), surgical injuries related to egg retrieval (bleeding, infection), embryo developmental arrest, and miscarriage after transfer. All treatments should be performed in a qualified reproductive medicine center under the full management of a professional reproductive team. This content is for popular science reference only and cannot replace clinical individualized diagnosis and treatment.
Comments (0)